Growth Metrics

Bio-Techne (TECH) Revenue Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 122.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.94%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 4.47%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 54.05%
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn 1.92%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.92%
Dec 31, 2025 2.90%
Sep 30, 2025 423.27%
Jun 30, 2025 3.22%
Mar 31, 2025 2.88%
Dec 31, 2024 3.32%
Sep 30, 2024 3.95%
Jun 30, 2024 5.72%
Mar 31, 2024 7.60%
Dec 31, 2023 6.72%
Sep 30, 2023 10.69%
Jun 30, 2023 19.67%
Mar 31, 2023 14.75%
Dec 31, 2022 13.67%
Sep 30, 2022 -77.82%
Jun 30, 2022 14.57%
Mar 31, 2022 16.24%
Dec 31, 2021 15.56%
Sep 30, 2021 16.51%
Jun 30, 2021 12.85%
Mar 31, 2021 14.10%
Dec 31, 2020 13.31%
Sep 30, 2020 12.19%
Jun 30, 2020 3.94%
Mar 31, 2020 10.56%
Dec 31, 2019 11.95%
Sep 30, 2019 11.96%
Jun 30, 2019 12.46%
Mar 31, 2019 12.17%
Dec 31, 2018 13.01%
Sep 30, 2018 13.19%
Jun 30, 2018 15.28%
Mar 31, 2018 12.83%
Dec 31, 2017 11.25%
Sep 30, 2017 10.06%
Jun 30, 2017 19.17%
Mar 31, 2017 14.66%
Dec 31, 2016 16.20%
Sep 30, 2016 15.09%
Jun 30, 2016 19.25%
Mar 31, 2016 17.38%
Dec 31, 2015 17.21%
Sep 30, 2015 14.42%
Jun 30, 2015 14.36%
Mar 31, 2015 10.93%
Dec 31, 2014 14.46%
Sep 30, 2014 11.81%
Jun 30, 2014 5.84%
Mar 31, 2014 7.80%
Dec 31, 2013 7.46%
Sep 30, 2013 8.03%
Jun 30, 2013 6.01%
Mar 31, 2013 4.84%
Dec 31, 2012 4.65%
Sep 30, 2012 4.08%